Showing results (41-50 of 172) with videos related to

Sort By:
Pageof 18
Arthritis and Rheumatism|January 1, 1991
Restoration of the DNA binding activity of estrogen receptor in MRL-lpr/lpr mice by a polyamine biosynthesis inhibitorT Thomas, U B Gunnia, J R Seibold, et al.
Agents and Actions|January 1, 1993
Studies on the effects of an ornithine decarboxylase inhibitor on lupus nephritis reveal a post-transcriptional modification of the enzymeH C Hsu, T Thomas, J R Seibold, et al.
The Journal of Laboratory and Clinical Medicine|June 1, 1985
Collagen synthesis and collagenase activity in dermal fibroblasts from patients with diabetes and digital sclerosisJ R Seibold, J Uitto, B B Dorwart, et al.
Arthritis and Rheumatism|November 1, 1982
Serum eosinophilotactic activity in eosinophilic fasciitisS I Wasserman, J R Seibold, T A Medsger, et al.
The Biochemical Journal|October 1, 1995
Triplex-DNA stabilization by hydralazine and the presence of anti-(triplex DNA) antibodies in patients treated with hydralazineT J Thomas, J R Seibold, L E Adams, et al.
Clinical and Experimental Immunology|October 1, 1984
Precipitating autoantibodies to mitochondrial proteins in progressive systemic sclerosisR C Gupta, J R Seibold, M R Krishnan, et al.
Kidney International|May 1, 1991
Successful treatment of lupus nephritis in MRL-lpr/lpr mice by inhibiting ornithine decarboxylaseU B Gunnia, P S Amenta, J R Seibold, et al.
Rheumatology (Oxford, England)|October 10, 2017
Pulmonary hypertension related to systemic sclerosis: points to consider for clinical trialsMarc Humbert, Manjit Singh, Daniel E Furst, et al.
Arthritis Research & Therapy|September 15, 2007
Clinical trials and basic research: defining mechanisms and improving treatment in connective tissue diseaseLewis J Rubin, Carol M Black, Christopher P Denton, et al.
Clinical and Experimental Rheumatology|April 1, 1984
Serotonin induced platelet aggregation in systemic sclerosisL T Friedhoff, J R Seibold, H C Kim, et al.
Pageof 18